IS8250A - Pýridasínón aldósa afsýringarkljúfshindrar - Google Patents

Pýridasínón aldósa afsýringarkljúfshindrar

Info

Publication number: IS8250A
Authority: IS; Iceland
Prior art keywords: antacids; pyridazinone aldose; pyridazinone; aldose; aldose antacids
Prior art date: 2001-03-30

Application number

IS8250A

Other languages

English (en)

Inventor

Lakshman Mylari Banavara

Original Assignee

Pfizer Products Inc.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-03-30

Filing date

2006-01-23

Publication date

2006-01-23

2006-01-23 Application filed by Pfizer Products Inc. filed Critical Pfizer Products Inc.

2006-01-23 Publication of IS8250A publication Critical patent/IS8250A/is

Links

-1 Pyridazinone aldose Chemical class 0.000 title 1
229940069428 antacid Drugs 0.000 title 1
239000003159 antacid agent Substances 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/82—Benzo [b] furans; Hydrogenated benzo [b] furans with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems

Landscapes

Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Diabetes (AREA)
Bioinformatics & Cheminformatics (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Hematology (AREA)
Obesity (AREA)
Endocrinology (AREA)
Emergency Medicine (AREA)
Urology & Nephrology (AREA)
Vascular Medicine (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Plural Heterocyclic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

IS8250A 2001-03-30 2006-01-23 Pýridasínón aldósa afsýringarkljúfshindrar IS8250A (is)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US28005101P	2001-03-30	2001-03-30
PCT/IB2002/000320 WO2002079198A1 (en)	2001-03-30	2002-01-31	Pyridazinone aldose reductase inhibitors

Publications (1)

Publication Number	Publication Date
IS8250A true IS8250A (is)	2006-01-23

Family

ID=23071435

Family Applications (3)

Application Number	Title	Priority Date	Filing Date
IS6845A IS2205B (is)	2001-03-30	2003-06-16	Pýridasínón aldósa afsýringarkljúfshindrar
IS8251A IS8251A (is)	2001-03-30	2006-01-23	Pýridasínón aldósa afsýringarkljúfshindrar
IS8250A IS8250A (is)	2001-03-30	2006-01-23	Pýridasínón aldósa afsýringarkljúfshindrar

Family Applications Before (2)

Application Number	Title	Priority Date	Filing Date
IS6845A IS2205B (is)	2001-03-30	2003-06-16	Pýridasínón aldósa afsýringarkljúfshindrar
IS8251A IS8251A (is)	2001-03-30	2006-01-23	Pýridasínón aldósa afsýringarkljúfshindrar

Country Status (43)

Country	Link
US (2)	US6579879B2 (is)
EP (3)	EP1491541B1 (is)
JP (1)	JP2004528319A (is)
KR (1)	KR100586138B1 (is)
CN (1)	CN1215067C (is)
AP (1)	AP2002002461A0 (is)
AR (1)	AR035798A1 (is)
AT (3)	ATE348100T1 (is)
AU (1)	AU2002226634B2 (is)
BG (1)	BG108179A (is)
BR (1)	BR0208571A (is)
CA (1)	CA2442476A1 (is)
CZ (1)	CZ20032563A3 (is)
DE (3)	DE60217930T2 (is)
DK (2)	DK1373259T3 (is)
EA (1)	EA006023B1 (is)
EC (1)	ECSP034671A (is)
EE (1)	EE200300470A (is)
ES (2)	ES2274369T3 (is)
GE (1)	GEP20053675B (is)
HR (1)	HRP20030752A2 (is)
HU (1)	HUP0303644A3 (is)
IL (1)	IL156462A0 (is)
IS (3)	IS2205B (is)
MA (1)	MA27003A1 (is)
MX (1)	MXPA03008850A (is)
MY (1)	MY134304A (is)
NO (1)	NO20034345D0 (is)
NZ (1)	NZ528406A (is)
OA (1)	OA12453A (is)
PA (1)	PA8541801A1 (is)
PE (1)	PE20030007A1 (is)
PL (1)	PL365294A1 (is)
PT (2)	PT1491540E (is)
SI (1)	SI1373259T1 (is)
SK (1)	SK11852003A3 (is)
TN (1)	TNSN02037A1 (is)
TW (1)	TWI245762B (is)
UA (1)	UA73236C2 (is)
UY (1)	UY27237A1 (is)
WO (1)	WO2002079198A1 (is)
YU (1)	YU71403A (is)
ZA (1)	ZA200304671B (is)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
KR100491282B1 (ko)	1996-07-24	2005-05-24	워너-램버트 캄파니 엘엘씨	통증 치료용 이소부틸가바 및 그의 유도체
ES2240657T3 (es) *	2001-02-28	2005-10-16	Pfizer Products Inc.	Compuestos de sulfonilpiridazinona utiles como inhibidores de aldosa reductasa.
CA2442476A1 (en) *	2001-03-30	2002-10-10	Pfizer Products Inc.	Pyridazinone aldose reductase inhibitors
AU761191B2 (en) *	2001-05-24	2003-05-29	Pfizer Products Inc.	Therapies for tissue damage resulting from ischemia
WO2003057691A1 (en) *	2002-01-09	2003-07-17	Pfizer Products Inc.	Process and intermediates for pyridazinone antidiabetic agents
US7419981B2 (en) *	2002-08-15	2008-09-02	Pfizer Inc.	Synergistic combinations of an alpha-2-delta ligand and a cGMP phosphodieterse 5 inhibitor
US20040092522A1 (en) *	2002-08-15	2004-05-13	Field Mark John	Synergistic combinations
US6872833B2 (en) *	2003-04-14	2005-03-29	Hoffmann-La Roche Inc.	Adenosine receptor ligands
US8017634B2 (en)	2003-12-29	2011-09-13	President And Fellows Of Harvard College	Compositions for treating obesity and insulin resistance disorders
US7262318B2 (en) *	2004-03-10	2007-08-28	Pfizer, Inc.	Substituted heteroaryl- and phenylsulfamoyl compounds
AR049384A1 (es)	2004-05-24	2006-07-26	Glaxo Group Ltd	Derivados de purina
JP4880591B2 (ja)	2004-06-04	2012-02-22	テバファーマシューティカルインダストリーズリミティド	イルベサルタンを含む医薬組成物
US20050288340A1 (en) *	2004-06-29	2005-12-29	Pfizer Inc	Substituted heteroaryl- and phenylsulfamoyl compounds
WO2006028565A2 (en) *	2004-06-30	2006-03-16	Whitehead Institute For Biomedical Research	Novel methods for high-throughput genome-wide location analysis
GB0514809D0 (en)	2005-07-19	2005-08-24	Glaxo Group Ltd	Compounds
US7741317B2 (en)	2005-10-21	2010-06-22	Bristol-Myers Squibb Company	LXR modulators
US7888376B2 (en)	2005-11-23	2011-02-15	Bristol-Myers Squibb Company	Heterocyclic CETP inhibitors
CN101370775A (zh) *	2006-01-13	2009-02-18	惠氏公司	作为5-羟基色胺受体配体的经磺酰基取代1h-吲哚
ES2379661T3 (es) *	2006-06-27	2012-04-30	Takeda Pharmaceutical Company Limited	Compuestos cíclicos condensados
US8404896B2 (en)	2006-12-01	2013-03-26	Bristol-Myers Squibb Company	N-((3-benzyl)-2,2-(bis-phenyl)-propan-1-amine derivatives as CETP inhibitors for the treatment of atherosclerosis and cardiovascular diseases
US8173645B2 (en) *	2007-03-21	2012-05-08	Takeda San Diego, Inc.	Glucokinase activators
JP2010043063A (ja)	2008-05-09	2010-02-25	Agency For Science Technology & Research	川崎病の診断及び治療
EP2509596B1 (en)	2009-12-08	2019-08-28	Case Western Reserve University	Gamma aminoacids for treating ocular disorders
US8916563B2 (en)	2010-07-16	2014-12-23	The Trustees Of Columbia University In The City Of New York	Aldose reductase inhibitors and uses thereof
US9296692B2 (en) *	2011-09-15	2016-03-29	Taipei Medical University	Use of indolyl and indolinyl hydroxamates for treating heart failure of neuronal injury
US9339542B2 (en) *	2013-04-16	2016-05-17	John L Couvaras	Hypertension reducing composition
BR112015026513A2 (pt)	2013-04-17	2017-07-25	Pfizer	derivados de n-piperidin-3-ilbenzamida para tratar as doenças cardiovasculares
CN103739547B (zh) *	2014-01-03	2015-09-02	沈阳药科大学	2-[6-甲氧基-3-(2,3-二氯苯基)甲基-4-氧代-1,4-二氢-1(4h)-喹啉基]乙酸的合成方法
WO2016055901A1 (en)	2014-10-08	2016-04-14	Pfizer Inc.	Substituted amide compounds
JP2018511616A (ja) *	2015-04-14	2018-04-26	ケースウエスタンリザーブユニバーシティ	短鎖デヒドロゲナーゼ活性を調節する組成物および方法
WO2017168174A1 (en)	2016-04-02	2017-10-05	N4 Pharma Uk Limited	New pharmaceutical forms of sildenafil
EP3352754B1 (en)	2016-06-21	2020-09-02	The Trustees of Columbia University in the City of New York	Aldose reductase inhibitors and methods of use thereof
WO2018002673A1 (en)	2016-07-01	2018-01-04	N4 Pharma Uk Limited	Novel formulations of angiotensin ii receptor antagonists
US10344002B2 (en)	2016-09-26	2019-07-09	Nusirt Sciences, Inc.	Compositions and methods for treating metabolic disorders
WO2018102552A1 (en)	2016-11-30	2018-06-07	Case Western Reserve University	Combinations of 15-pgdh inhibitors with corcosteroids and/or tnf inhibitors and uses thereof
US11718589B2 (en)	2017-02-06	2023-08-08	Case Western Reserve University	Compositions and methods of modulating short-chain dehydrogenase
IL272246B2 (en)	2017-07-28	2026-01-01	Applied Therapeutics Inc	History of 2-(4-oxo/thioketone/azo-3-((substituted)benzo[d]thiazol-2-yl)methyl)- 3,4-dihydrothieno[3,4-d]pyridazin-1-yl)acetic acid for use as an aldose reductase inhibitor for the treatment of galactosemia or prevention of galactosemia-related complications
KR102921276B1 (ko)	2018-11-21	2026-02-03	케이스 웨스턴 리저브 유니버시티	단쇄 데히드로게나아제 활성을 조절하는 조성물 및 방법
RS66416B1 (sr)	2019-01-18	2025-02-28	Astrazeneca Ab	6'-[[(1s,3s)-3-[[5-(difluorometoksi)-2-pirimidinil]amino]ciklopentil]amino][1(2h),3'-bipiridin]-2-on kao inhibitor pcsk9 i metode njegove primene
KR20220003529A (ko)	2019-04-01	2022-01-10	어플라이드 테라퓨틱스 인크.	알도스 리덕타제의 억제제
MX2021013511A (es)	2019-05-07	2022-02-23	Univ Miami	Tratamiento y deteccion de neuropatias heredadas y trastornos asociados.
TW202108559A (zh)	2019-05-31	2021-03-01	美商醫肯納腫瘤學公司	Tead抑制劑及其用途
BR112021024108A2 (pt)	2019-05-31	2022-03-22	Ikena Oncology Inc	Inibidores de tead e usos dos mesmos
WO2022120353A1 (en) *	2020-12-02	2022-06-09	Ikena Oncology, Inc.	Tead inhibitors and uses thereof

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IE47592B1 (en)	1977-12-29	1984-05-02	Ici Ltd	Enzyme inhibitory phthalazin-4-ylacetic acid derivatives, pharmaceutical compositions thereof,and process for their manufacture
US4939140A (en)	1985-11-07	1990-07-03	Pfizer Inc.	Heterocyclic oxophthalazinyl acetic acids
US4996204A (en)	1989-05-11	1991-02-26	Pfizer Inc.	Pyrido[2,3-d]pyridazinones as aldose reductase inhibitors
FR2647676A1 (fr)	1989-06-05	1990-12-07	Union Pharma Scient Appl	Nouveaux derives de pyridazinone, leurs procedes de preparation, medicaments les contenant, utiles notamment comme inhibiteurs de l'aldose reductase
EP0516860A4 (en) *	1990-11-30	1993-12-01	Tsumura & Co.	Chromone derivative and aldose reductase inhibitor containing the same as active ingredient
FI934222A7 (fi)	1991-03-28	1993-09-27	Pfizer	Pyridatsinonietikkahappoja
US5834466A (en)	1994-12-22	1998-11-10	The Regents Of The University Of California	Method for protecting of heart by limiting metabolic and ionic abnormalities developed during ischemia, following ischemia or resulting from ischemia
TWI238064B (en)	1995-06-20	2005-08-21	Takeda Chemical Industries Ltd	A pharmaceutical composition for prophylaxis and treatment of diabetes
BR9813216A (pt) *	1997-09-24	2000-08-29	Orion Corp	Biésteres de 1-oxa, aza e tianaftalen-2-onas como inibidores de fosfolamban
FR2822827B1 (fr) *	2001-03-28	2003-05-16	Sanofi Synthelabo	Nouveaux derives de n-(arylsulfonyl) beta-aminoacides comportant un groupe aminomethyle substitue, leur procede de preparation et les compositions pharmaceutiques en contenant
CA2442476A1 (en) *	2001-03-30	2002-10-10	Pfizer Products Inc.	Pyridazinone aldose reductase inhibitors
IL157935A0 (en) *	2001-04-30	2004-03-28	Pfizer Prod Inc	Combinations of aldose reductase inhibitors and cyclooxygenase-2 inhibitors
WO2003057691A1 (en) *	2002-01-09	2003-07-17	Pfizer Products Inc.	Process and intermediates for pyridazinone antidiabetic agents

2002
- 2002-01-31 CA CA002442476A patent/CA2442476A1/en not_active Abandoned
- 2002-01-31 DE DE60217930T patent/DE60217930T2/de not_active Expired - Fee Related
- 2002-01-31 EP EP04023150A patent/EP1491541B1/en not_active Expired - Lifetime
- 2002-01-31 JP JP2002577823A patent/JP2004528319A/ja active Pending
- 2002-01-31 PT PT04023149T patent/PT1491540E/pt unknown
- 2002-01-31 MX MXPA03008850A patent/MXPA03008850A/es active IP Right Grant
- 2002-01-31 EA EA200300673A patent/EA006023B1/ru not_active IP Right Cessation
- 2002-01-31 KR KR1020037012753A patent/KR100586138B1/ko not_active Expired - Fee Related
- 2002-01-31 AT AT04023149T patent/ATE348100T1/de not_active IP Right Cessation
- 2002-01-31 DE DE60216823T patent/DE60216823T2/de not_active Expired - Fee Related
- 2002-01-31 SK SK1185-2003A patent/SK11852003A3/sk unknown
- 2002-01-31 NZ NZ528406A patent/NZ528406A/en unknown
- 2002-01-31 IL IL15646202A patent/IL156462A0/xx unknown
- 2002-01-31 CN CNB028076001A patent/CN1215067C/zh not_active Expired - Fee Related
- 2002-01-31 ES ES04023149T patent/ES2274369T3/es not_active Expired - Lifetime
- 2002-01-31 HR HR20030752A patent/HRP20030752A2/hr not_active Application Discontinuation
- 2002-01-31 YU YU71403A patent/YU71403A/sh unknown
- 2002-01-31 EP EP04023149A patent/EP1491540B1/en not_active Expired - Lifetime
- 2002-01-31 AU AU2002226634A patent/AU2002226634B2/en not_active Ceased
- 2002-01-31 HU HU0303644A patent/HUP0303644A3/hu unknown
- 2002-01-31 AT AT04023150T patent/ATE352551T1/de not_active IP Right Cessation
- 2002-01-31 DE DE60202452T patent/DE60202452C5/de not_active Expired - Fee Related
- 2002-01-31 OA OA1200300222A patent/OA12453A/en unknown
- 2002-01-31 BR BR0208571-2A patent/BR0208571A/pt not_active IP Right Cessation
- 2002-01-31 EE EEP200300470A patent/EE200300470A/xx unknown
- 2002-01-31 WO PCT/IB2002/000320 patent/WO2002079198A1/en not_active Ceased
- 2002-01-31 EP EP02716247A patent/EP1373259B1/en not_active Expired - Lifetime
- 2002-01-31 ES ES02716247T patent/ES2231681T3/es not_active Expired - Lifetime
- 2002-01-31 UA UA2003098846A patent/UA73236C2/uk unknown
- 2002-01-31 DK DK02716247T patent/DK1373259T3/da active
- 2002-01-31 DK DK04023149T patent/DK1491540T3/da active
- 2002-01-31 AT AT02716247T patent/ATE286049T1/de active
- 2002-01-31 GE GE5314A patent/GEP20053675B/en unknown
- 2002-01-31 SI SI200230071T patent/SI1373259T1/xx unknown
- 2002-01-31 PL PL02365294A patent/PL365294A1/xx not_active Application Discontinuation
- 2002-01-31 PT PT02716247T patent/PT1373259E/pt unknown
- 2002-03-21 US US10/104,664 patent/US6579879B2/en not_active Expired - Fee Related
- 2002-03-22 PA PA20028541801A patent/PA8541801A1/es unknown
- 2002-03-27 AR ARP020101134A patent/AR035798A1/es unknown
- 2002-03-27 MY MYPI20021093A patent/MY134304A/en unknown
- 2002-03-27 PE PE2002000246A patent/PE20030007A1/es not_active Application Discontinuation
- 2002-03-27 UY UY27237A patent/UY27237A1/es not_active Application Discontinuation
- 2002-03-28 AP APAP/P/2002/002461A patent/AP2002002461A0/en unknown
- 2002-03-29 TW TW091106386A patent/TWI245762B/zh not_active IP Right Cessation
- 2002-03-29 TN TNTNSN02037A patent/TNSN02037A1/fr unknown
- 2002-03-31 CZ CZ20032563A patent/CZ20032563A3/cs unknown
2003
- 2003-02-20 US US10/370,895 patent/US6849629B2/en not_active Expired - Fee Related
- 2003-06-16 IS IS6845A patent/IS2205B/is unknown
- 2003-06-17 ZA ZA200304671A patent/ZA200304671B/en unknown
- 2003-06-25 EC EC2003004671A patent/ECSP034671A/es unknown
- 2003-09-17 MA MA27314A patent/MA27003A1/fr unknown
- 2003-09-17 BG BG108179A patent/BG108179A/xx unknown
- 2003-09-29 NO NO20034345A patent/NO20034345D0/no unknown
2006
- 2006-01-23 IS IS8251A patent/IS8251A/is unknown
- 2006-01-23 IS IS8250A patent/IS8250A/is unknown

Also Published As

Publication number	Publication date
US6849629B2 (en)	2005-02-01
DK1373259T3 (da)	2005-03-29
TWI245762B (en)	2005-12-21
ES2274369T3 (es)	2007-05-16
IS2205B (is)	2007-02-15
ECSP034671A (es)	2003-08-29
MA27003A1 (fr)	2004-12-20
IL156462A0 (en)	2004-01-04
AP2002002461A0 (en)	2002-06-30
IS8251A (is)	2006-01-23
BG108179A (en)	2004-09-30
GEP20053675B (en)	2005-11-25
DE60202452C5 (de)	2006-11-23
MXPA03008850A (es)	2003-12-04
EP1373259A1 (en)	2004-01-02
OA12453A (en)	2006-05-24
HUP0303644A2 (hu)	2004-03-01
KR20030088484A (ko)	2003-11-19
KR100586138B1 (ko)	2006-06-07
NO20034345L (no)	2003-09-29
EA006023B1 (ru)	2005-08-25
HUP0303644A3 (en)	2008-06-30
UY27237A1 (es)	2002-12-31
SK11852003A3 (sk)	2004-07-07
ZA200304671B (en)	2004-06-25
YU71403A (sh)	2006-05-25
EP1491541B1 (en)	2007-01-24
CZ20032563A3 (cs)	2004-05-12
DK1491540T3 (da)	2007-03-26
JP2004528319A (ja)	2004-09-16
ATE352551T1 (de)	2007-02-15
DE60216823T2 (de)	2007-10-04
NZ528406A (en)	2004-03-26
HK1061678A1 (en)	2004-09-30
UA73236C2 (en)	2005-06-15
AR035798A1 (es)	2004-07-14
CA2442476A1 (en)	2002-10-10
ATE286049T1 (de)	2005-01-15
NO20034345D0 (no)	2003-09-29
TNSN02037A1 (fr)	2005-12-23
DE60216823D1 (de)	2007-01-25
DE60217930T2 (de)	2007-10-18
DE60202452T2 (de)	2006-02-09
US6579879B2 (en)	2003-06-17
PA8541801A1 (es)	2002-10-28
DE60202452D1 (de)	2005-02-03
US20020143017A1 (en)	2002-10-03
WO2002079198A1 (en)	2002-10-10
CN1500087A (zh)	2004-05-26
DE60217930D1 (de)	2007-03-15
CN1215067C (zh)	2005-08-17
ATE348100T1 (de)	2007-01-15
SI1373259T1 (en)	2005-04-30
EP1491541A1 (en)	2004-12-29
EP1373259B1 (en)	2004-12-29
IS6845A (is)	2003-06-16
PL365294A1 (en)	2004-12-27
EP1491540B1 (en)	2006-12-13
EE200300470A (et)	2004-02-16
EA200300673A1 (ru)	2003-12-25
HRP20030752A2 (en)	2005-06-30
ES2231681T3 (es)	2005-05-16
MY134304A (en)	2007-12-31
AU2002226634B2 (en)	2007-01-25
PT1491540E (pt)	2007-01-31
PT1373259E (pt)	2005-03-31
PE20030007A1 (es)	2003-01-28
EP1491540A1 (en)	2004-12-29
US20030162784A1 (en)	2003-08-28
BR0208571A (pt)	2004-03-23

Publication	Publication Date	Title
IS8250A (is)	2006-01-23	Pýridasínón aldósa afsýringarkljúfshindrar
DK1421841T3 (da)	2007-12-17	Mejetærsker
DE60212857D1 (de)	2006-08-10	Thermischer schnappschalter
DK1361880T3 (da)	2006-01-23	6-substituerede pyrido-pyrimidiner
PT1411764E (pt)	2005-05-31	Cerca
DE60207168D1 (de)	2005-12-15	Lüftungsanlage
NO20042742L (no)	2004-08-24	Pyrimidinforbindelser
NO20031562D0 (no)	2003-04-07	Vinterdekk
DE60216425D1 (de)	2007-01-11	Ausgleichswellenzusammenbau
DE60210848D1 (de)	2006-06-01	Verbinder
DE50200795D1 (de)	2004-09-16	Mikroventil
DE60221366D1 (de)	2007-09-06	Verbinder
DE50210548D1 (de)	2007-09-06	Spannbaugruppe
DE60233695D1 (de)	2009-10-29	Verbinder
DE60231053D1 (de)	2009-03-19	Stirlingmaschinenzusammenbau
DE50108179D1 (de)	2005-12-29	Verbinder
ATE405973T1 (de)	2008-09-15	Steckverbindung
DE60126833D1 (de)	2007-04-05	Flugzeugsitzkonstruktion
ES1050823Y (es)	2002-09-16	Casco salvavidas
DE10295574D2 (de)	2004-10-28	Geräusch-gesteuertes Beatmungsgerät
FI5142U1 (fi)	2001-11-28	Jänisräikkä
UA5367S (uk)	2001-11-15	Навіс
FI20011758A0 (fi)	2001-09-05	Henkilökohtainen virtsauslaite
NO20010670D0 (no)	2001-02-08	SMS pengeinnsamling
FI5472U1 (fi)	2002-07-30	Puhelaite